Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk-Reference-Cited by-同舟云学术

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk

Published:2019-10-01 Issue:10 Volume:4 Page:969
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Kohli-Lynch Ciaran N.¹²,Bellows Brandon K.¹,Thanassoulis George³,Zhang Yiyi¹,Pletcher Mark J.⁴,Vittinghoff Eric⁴,Pencina Michael J.⁵,Kazi Dhruv⁶,Sniderman Allan D.³,Moran Andrew E.¹

Affiliation:

1. Division of General Medicine, Columbia University Medical Center, New York, New York

2. Health Economics and Health Technology Assessment, University of Glasgow, Glasgow, United Kingdom

3. Division of Cardiology, McGill University, Quebec City, Quebec, Canada

4. Department of Epidemiology & Biostatistics, University of California at San Francisco School of Medicine

5. Duke Clinical Research Institute, Durham, North Carolina

6. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2748763/jamacardiology_kohlilynch_2019_oi_190047.pdf

Reference40 articles.

1. Statins for the primary prevention of cardiovascular disease.;Taylor;Cochrane Database Syst Rev,2013

2. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Grundy;J Am Coll Cardiol,2019

3. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult.;Anderson;Can J Cardiol,2016

4. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.;Stone;Circulation,2014

5. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.;Bibbins-Domingo;JAMA,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study;The Lancet Regional Health - Europe;2024-05

2. The Causal-Benefit Model to Prevent Cardiovascular Events;JACC: Advances;2024-03

3. An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation;Lipids in Health and Disease;2024-02-08

4. Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease;Journal of Clinical Medicine;2023-09-23

5. Interpretable Policies and the Price of Interpretability in Hypertension Treatment Planning;Manufacturing & Service Operations Management;2023-07-18